These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11353541)

  • 1. A robust method for the preparation and purification of antibody/streptavidin conjugates.
    Hylarides MD; Mallett RW; Meyer DL
    Bioconjug Chem; 2001; 12(3):421-7. PubMed ID: 11353541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccines prepared with sialyl-Tn and sialyl-Tn trimers using the 4-(4-maleimidomethyl)cyclohexane-1-carboxyl hydrazide linker group result in optimal antibody titers against ovine submaxillary mucin and sialyl-Tn-positive tumor cells.
    Ragupathi G; Howard L; Cappello S; Koganty RR; Qiu D; Longenecker BM; Reddish MA; Lloyd KO; Livingston PO
    Cancer Immunol Immunother; 1999 Apr; 48(1):1-8. PubMed ID: 10235483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of anti-tenascin monoclonal antibody-streptavidin conjugates for pretargeting applications.
    Foulon CF; Bigner DD; Zalutsky MR
    Bioconjug Chem; 1999; 10(5):867-76. PubMed ID: 10502355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
    Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization, and biological evaluation of a streptavidin-chimeric t84.66 conjugate for antibody pretargeting.
    Jia F; Shelton TD; Lewis MR
    Cancer Biother Radiopharm; 2007 Oct; 22(5):654-64. PubMed ID: 17979568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo evaluation of streptavidin immunoconjugates of the second generation TAG-72 monoclonal antibody CC49.
    Ngai WM; Reilly RM; Polihronis J; Shpitz B
    Nucl Med Biol; 1995 Jan; 22(1):77-86. PubMed ID: 7735174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a streptavidin-anti-carcinoembryonic antigen antibody, radiolabeled biotin pretargeting method for radioimmunotherapy of colorectal cancer. Reagent development.
    Karacay H; Sharkey RM; Govindan SV; McBride WJ; Goldenberg DM; Hansen HJ; Griffiths GL
    Bioconjug Chem; 1997; 8(4):585-94. PubMed ID: 9258459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibody Fab' fragment cross-linking using equilibrium transfer alkylation reagents. A strategy for site-specific conjugation of diagnostic and therapeutic agents with F(ab')2 fragments.
    Wilbur DS; Stray JE; Hamlin DK; Curtis DK; Vessella RL
    Bioconjug Chem; 1994; 5(3):220-35. PubMed ID: 7918742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioconjugation of Antibodies to Horseradish Peroxidase (HRP).
    Hnasko RM
    Methods Mol Biol; 2015; 1318():43-50. PubMed ID: 26160562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid phase assembly of defined protein conjugates.
    Russell JC; Colpitts TL; Holets-McCormack SR; Spring TG; Stroupe SD; Vogt AD; Wong ST
    Bioconjug Chem; 2002; 13(5):958-65. PubMed ID: 12236777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An anti-MUC1 antibody-calicheamicin conjugate for treatment of solid tumors. Choice of linker and overcoming drug resistance.
    Hamann PR; Hinman LM; Beyer CF; Greenberger LM; Lin C; Lindh D; Menendez AT; Wallace R; Durr FE; Upeslacis J
    Bioconjug Chem; 2005; 16(2):346-53. PubMed ID: 15769088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced stability in vitro and in vivo of immunoconjugates prepared with 5-methyl-2-iminothiolane.
    Carroll SF; Bernhard SL; Goff DA; Bauer RJ; Leach W; Kung AH
    Bioconjug Chem; 1994; 5(3):248-56. PubMed ID: 7918744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates.
    Shen BQ; Xu K; Liu L; Raab H; Bhakta S; Kenrick M; Parsons-Reponte KL; Tien J; Yu SF; Mai E; Li D; Tibbitts J; Baudys J; Saad OM; Scales SJ; McDonald PJ; Hass PE; Eigenbrot C; Nguyen T; Solis WA; Fuji RN; Flagella KM; Patel D; Spencer SD; Khawli LA; Ebens A; Wong WL; Vandlen R; Kaur S; Sliwkowski MX; Scheller RH; Polakis P; Junutula JR
    Nat Biotechnol; 2012 Jan; 30(2):184-9. PubMed ID: 22267010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiplex ELISA Using Oligonucleotide Tethered Antibodies.
    Matson RS
    Methods Mol Biol; 2015; 1318():181-95. PubMed ID: 26160576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cross-linked monoclonal antibody fragment for improved tumor targeting.
    Stalteri MA; Mather SJ
    Bioconjug Chem; 1995; 6(2):179-86. PubMed ID: 7599261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretargeting for cancer radioimmunotherapy with bispecific antibodies: role of the bispecific antibody's valency for the tumor target antigen.
    Karacay H; Sharkey RM; McBride WJ; Griffiths GL; Qu Z; Chang K; Hansen HJ; Goldenberg DM
    Bioconjug Chem; 2002; 13(5):1054-70. PubMed ID: 12236788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation of immunoconjugates using antibody oligosaccharide moieties.
    Vogel CW
    Methods Mol Biol; 2004; 283():87-108. PubMed ID: 15197304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel cross-linked enzyme-antibody conjugates for Western blot and ELISA.
    Simons B; Kaplan H; Hefford MA
    J Immunol Methods; 2006 Aug; 315(1-2):88-98. PubMed ID: 16905142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CBTF: new amine-to-thiol coupling reagent for preparation of antibody conjugates with increased plasma stability.
    Kolodych S; Koniev O; Baatarkhuu Z; Bonnefoy JY; Debaene F; Cianférani S; Van Dorsselaer A; Wagner A
    Bioconjug Chem; 2015 Feb; 26(2):197-200. PubMed ID: 25614935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjugation of catalase to a carrier antibody via a streptavidin-biotin cross-linker.
    Muzykantov VR
    Biotechnol Appl Biochem; 1997 Oct; 26(2):103-9. PubMed ID: 9357106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.